Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

MRKR Relative to the S&P 500

MRKR Relative to the Sector

Seasonal Chart Analysis

Analysis of the Marker Therapeutics, Inc. (NASD:MRKR) seasonal charts above shows that a Buy Date of April 12 and a Sell Date of July 5 has resulted in a geometric average return of 15.06% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 115.06% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.

To download MRKR seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: MRKR